申请人:REVOLUTION MEDICINES INC
公开号:WO2022235864A1
公开(公告)日:2022-11-10
The disclosure features macrocyclic compounds, and pharmaceutical compositions and protein complexes thereof, capable of inhibiting Ras proteins, and their uses in the treatment of cancers.
该披露涉及大环化合物、以及其制备的药物组合物和蛋白质复合物,能够抑制Ras蛋白,并将其用于治疗癌症。